FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
VIMCX
Price
$58.71
Change
+$0.35 (+0.60%)
Updated
Aug 21 closing price
Net Assets
1.63B
Interact to see
Advertisement

FSMAX vs VIMCX

FSMAX vs VIMCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. VIMCX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and VIMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. VIMCX (1.63B). FSMAX pays higher dividends than VIMCX: FSMAX (0.50) vs VIMCX (0.00). FSMAX was incepted earlier than VIMCX: FSMAX (15 years) vs VIMCX (17 years). VIMCX (1.02) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 23.00 vs. VIMCX (16.00). FSMAX has a lower initial minimum investment than VIMCX: FSMAX (0) vs VIMCX (100000). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. VIMCX (-3.82). FSMAX return over 5 years is better than : 40.14 vs. VIMCX (3.53).
FSMAXVIMCXFSMAX / VIMCX
Total Expense Ratio0.040.954%
Annual Report Gross Expense Ratio0.041.023%
Fund Existence15 years17 years-
Gain YTD16.9372.229760%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B1.63B2,454%
Annual Yield % from dividends0.500.00-
Returns for 1 year23.68-3.82-620%
Returns for 3 years72.7410.52691%
Returns for 5 years40.143.531,138%
Returns for 10 years134.49142.6094%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIICX51.040.58
+1.15%
American Funds Intl Gr and Inc 529-C
FCUCX20.460.08
+0.39%
NYLI PineStone U.S. Equity Class C
ISCGX5.500.02
+0.36%
Transamerica Small Cap Growth I
HFDCX20.760.06
+0.29%
Hartford Schroders US MidCap Opps C
FHCCX43.67N/A
N/A
Fidelity Advisor Health Care C